← Back to Search

Alcohol Abstinence + Exercise for High Blood Pressure

N/A
Recruiting
Led By Chueh-Lung Hwang, PhD
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through out the study participation (~3 months)
Awards & highlights

Study Summary

This trial will have two phases. In the first, researchers will compare blood pressure, microvascular function, and sympathetic nerve activity in mid-life adults who binge drink with those who abstain or drink moderately. In the second phase, they will examine the effect of 8 weeks of aerobic exercise training on those same measures in the binge drinkers.

Who is the study for?
This trial is for non-smoking men and women aged 50-64 who are postmenopausal, do not use drugs, and have varying alcohol consumption habits. It's not for those with high blood pressure, recent infections, diabetes, heart/liver/kidney disease, obesity or high cholesterol. Regular exercisers and hormone therapy users are also excluded.Check my eligibility
What is being tested?
The study investigates how abstaining from alcohol and engaging in an 8-week aerobic exercise program affects blood pressure and vascular function in mid-life adults who binge drink compared to those who don't drink or drink moderately.See study design
What are the potential side effects?
While the trial itself may not directly cause side effects, participants might experience withdrawal symptoms if they're used to heavy drinking. Exercise can lead to muscle soreness or injury if not done properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through out the study participation (~3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through out the study participation (~3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of high-intensity interval training
Secondary outcome measures
Changes in alcohol intake
Body Weight Changes
Changes in microvascular function
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Exercise GroupExperimental Treatment2 Interventions
Binge drinkers who have been assigned to exercise group will receive baseline assessment, 8-week exercise training plus alcohol abstinence intervention, and post-intervention assessment.
Group II: Non-exercise GroupActive Control1 Intervention
Binge drinkers who have been assigned to non-exercise group will receive baseline assessment, 8-week alcohol abstinence intervention, and post-intervention assessment.
Group III: Alcohol abstainer/moderate drinker groupActive Control1 Intervention
Alcohol abstainer/moderate drinker will complete baseline assessment only and will not receive any intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Training
2011
Completed Phase 3
~1440

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,365,390 Total Patients Enrolled
The University of Texas at ArlingtonLead Sponsor
43 Previous Clinical Trials
4,883 Total Patients Enrolled
Chueh-Lung Hwang, PhDPrincipal InvestigatorUniversity of Texas at Arlington

Media Library

Alcohol Abstinence Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05522075 — N/A
Excessive Alcohol Consumption Research Study Groups: Exercise Group, Non-exercise Group, Alcohol abstainer/moderate drinker group
Excessive Alcohol Consumption Clinical Trial 2023: Alcohol Abstinence Intervention Highlights & Side Effects. Trial Name: NCT05522075 — N/A
Alcohol Abstinence Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05522075 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participating in this clinical experiment?

"To be accepted into this trial, applicants must have abstained from alcohol and are age 50-64. The study is enrolling 55 people in total."

Answered by AI

Are there any vacancies left for participants in this trial?

"According to the data on clinicaltrials.gov, this particular medical study is no longer recruiting patients; it was posted on October 1st 2022 and last modified September 15th 2022. Nonetheless, there are currently 721 other trials that require participants."

Answered by AI

Does the enrollment criteria for this research endeavor extend to individuals under 25 years of age?

"This clinical trial calls for participants aged between 50 and 64. In contrast, 85 studies are designed to accommodate individuals below 18 years old and 551 research projects target those who surpass the age of 65."

Answered by AI

Who else is applying?

What site did they apply to?
University of Texas at Arlington
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
2022. "Reducing Blood Pressure in Mid-life Adult Binge Drinkers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05522075.
~14 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top